MIRA INFORM REPORT

 

 

 

Report Date :

23.05.2008

 

IDENTIFICATION DETAILS

 

Name :

BHALANI BIOMEDICALS PRIVATE IIMITED

 

 

Registered Office :

225, Hind Rajasthan Building, D S Phalke Road, Dadar (West), Mumbai – 400015, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2006

 

 

Date of Incorporation :

3.06.2005

 

 

Com. Reg. No.:

11-153754

 

 

CIN No.:

[Company Identification No.]

U33100MH2005PTC153754

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMB16901D

 

 

PAN No.:

[Permanent Account No.]

AACCB6309E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

To carry on all or any of the business as Distributor, C and F Agent, Commission agents, merchant, traders, buying agents, selling agents, brokers, adatias, buyers, sellers, importers, exporters, and dealers in all Biomedical instrument, parts and other accessories and all other medical instruments, equipments and machineries.

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Maximum Credit Limit :

USD 600

 

 

Status :

Small Company

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a relatively small company having satisfactory track. Directors are reported as experienced and respectable businessmen. Trade relations are reported as fair. Business is active. Payments are however reported as usually correct and as per commitments.

 

The company can be considered for small business dealings at usual trade terms and conditions.

 

In absence of communication details from any sources, we sent information request letter through courier but management has not responded, yet.

 

If any further details are made available we shall supplement the same.

 

LOCATIONS

 

Registered Office :

225,Hind Rajasthan Building, D S Phalke Road, Dadar (West), Mumbai – 400015, Maharashtra, India

Tel No.:

91-22-40765333

E-Mail :

bhalanibiomedicals@yahoo.co.in

Area:

600 Sq.fts

Location:

Owned

 

DIRECTORS

 

Name :

Mr. Hiren S. Bhalani

Designation :

Director

Address :

F – 621, Garden court building L.B.S. Marg. Ghatkopar (West), Mumbai – 400086, Maharashtra, India

Date of Appointment :

03.06.2005

 

 

Name :

Mr. Hemal S. Bhalani

Designation :

Director

Address :

F – 621, Garden court building L.B.S. Marg. Ghatkopar (West), Mumbai – 400086, Maharashtra, India

Date of Appointment :

03.06.2005

 

 

Name :

Mrs. Jigna H. Bhalani

Designation :

Director

Address :

F – 621, Garden court building L.B.S. Marg. Ghatkopar (West), Mumbai – 400086, Maharashtra, India

Date of Appointment :

03.06.2005

 

 

Name :

Mr. Shahsikant C. Bhalani

Designation :

Director

Address :

F – 621, Garden court building L.B.S. Marg. Ghatkopar (West), Mumbai – 400086, Maharashtra, India

Date of Appointment :

03.06.2005

 

 

Name :

Mrs. Chandrika S.Bhalani

Designation :

Director

Address :

F – 621, Garden court building L.B.S. Marg. Ghatkopar (West), Mumbai – 400086, Maharashtra, India

Date of Appointment :

03.06.2005

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders (as on 31.03.2006):-

 

No. of Shares

Mr. Hemal S. Bhalani

 

2000

Mr. Hiren S. Bhalani

 

2000

Mrs. Jigna H. Bhalani

 

2000

Mr. Shahsikant C. Bhalani

 

2000

Mrs. Chandrika S.Bhalani

 

2000

 

Total

10000

 

 

 

Category (as on 31.03.2006):-

 

Percentage of Holding

Directors or relative of directors

 

100.00

 

BUSINESS DETAILS

 

Line of Business :

To carry on all or any of the business as Distributor, C and F Agent, Commission agents, merchant, traders, buying agents, selling agents, brokers, adatias, buyers, sellers, importers, exporters, and dealers in all Biomedical instrument, parts and other accessories and all other medical instruments, equipments and machineries.

 

GENERAL INFORMATION

 

No. of Employees :

8

 

 

Bankers :

Canara Bank, 12, Shishu Mandir Building, 12 G.S.Lane, Parel, Mumbai – 400012, Maharashtra, India

 

 

Facilities:

Credit Facility - Rs. 25.000 millions

 

 

Banking Relations :

 ------

 

 

Auditors :

 

Name :

Sarika Shah And Company

Chartered Accountants

Address :

6, Ramnik Villa, Laxminarayan Mandir Marg. Ghatkopar (West), Mumbai – 400086, Maharashtra, India

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

10000

Equity shares

Rs.10/- each

Rs.0.100 million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

10000

Equity shares

Rs.10/- each

Rs.0.100million

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

 

31.03.2006

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

0.100

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

0.040

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

0.140

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.000

2] Unsecured Loans

 

 

0.650

TOTAL BORROWING

 

 

0.650

DEFERRED TAX LIABILITIES

 

 

 

 

 

 

 

TOTAL

 

 

0.790

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

0.000

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

0.000

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

0.254

 

Sundry Debtors

 

 

0.140

 

Cash & Bank Balances

 

 

0.236

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

0.185

Total Current Assets

 

 

0.815

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

 

 

0.025

 

Provisions

 

 

0.000

Total Current Liabilities

 

 

0.025

Net Current Assets

 

 

0.790

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

0.790

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

 

 

31.03.2006

Sales Turnover

 

 

0.389

Other Income

 

 

0.000

Total Income

 

 

0.389

 

 

 

 

Profit/(Loss) Before Tax

 

 

0.060

Provision for Taxation

 

 

0.000

Profit/(Loss) After Tax

 

 

0.060

 

 

 

 

Total Expenditure

 

 

0.329

 

KEY RATIOS

 

PARTICULARS

 

 

 

 

31.03.2006

PAT / Total Income

(%)

 

 

15.42

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

 

 

15.42

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

 

0.07

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

 

0.42

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

 

 

0.17

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

 

32.60

 

LOCAL AGENCY FURTHER INFORMATION

 

FORM 8:-

Name of the company

BHALANI BIOMEDICALS PRIVATE LIMITED

Presented By

Canara Bank and Bhalani Biomedicals private Limited

1) Date and description of instrument creating the change

13.09.2005

Common Hypothecation Agreement

2) Amount secured by the charge/amount owing on the securities of charge

Rs.5.500 millions

 

                   (Rs. In millions)

Cash Credit  1.500

Guarantee     4.000

          Total    5.500

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

1) All stock of goods such as raw materials goods in process, finished and manufactured goods and other items of stocks in trade and stores, spares, components, machinery, vehicles, furniture and fixture and all other movable goods and properties of every description of the Borrower wherever situated whether at the Borrower’s factories, places of business, residence (if applicable), godowns or in transit or in the custody of processors, warehouse agents or other or wherever else the same may be situated, lying or being including any such raw materials, articles or goods, stores, spares, components, stocks in trade and all description of movable property in the course of delivery to the Borrow.

4) Gist of the terms and conditions and extent and operation of the charge.

1) Interest @3.5% above PLR or at such other rates as may be fled by the Bank

 

2) Borrower shall maintain such 25% Margin of security as is stipulated by the Bank from time to time

5) Name and Address and description of the person entitled to the charge.

Canara Bank

12, Shishu Mandir, G.S.Lane, Parel, Mumbai – 400012, Maharashtra, India

 

Corporate identity number (CIN) Foreign company registration number

U33100MH2005PTC153754

Name of the Company

BHALANI BIOMEDICALS PRIVATE LIMITED

Address

225, Hind Rajasthan Building, D.S. Phalke Road, Dadar (East), Mumbai – 400014, Maharashtra

This form is for

Modification of Charge

Type of Charge

Book Debts, Movable property (not being pledge), Floating charge

Particulars of the charge holder 

Canara Bank

12, shishu Mandir, G.S.Lane, Parel, Mumbai – 400012, Maharashtra

managermcity0224@canbank.co.in

Date of the instrument creating charge

20.11.2006

Amount secured by the charge

Rs. 25.000 millions

Brief of the principal terms and conditions 

Interest Rate @ 5.5% p.a. above on going Benchmark PLR with a minimum of 17% p.a. compound monthly

 

Terms of repayment – on Demand

 

Margin – As may be stipulated by Bank form time to time.

 

Extent and operation of the charge – the  facility together with interest/commission, costs, charges, expenses and other monies payable there under shall be secured against the property.

Brief description of the instrument modifying the charge under section 

All goods and commodities purchased acquired, received under the said credit facilities now lying or hereinafter stored at the godowns, yards and premises or lying at any other place wheresoever or in respect of which the borrower can make or effect or purpose to make any deposit, hypothecation or charge.

Particular of the present modification 

The Bank has increased the credit facility by way of Bank guarantee from Rs.10.000 millions to Rs.25.000 millions. All other terms and conditions shall remain same.

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.43.15

UK Pound

1

Rs.85.08

Euro

1

Rs.68.10

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

2

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

1

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

25

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions